Novo Nordisk's pricing techniques in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of cost gouging, mentioning the stark distinction among U.S. costs and those in Europe and copyright. inflammation of one's pancreas (pancreatitis)